These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


929 related items for PubMed ID: 28870151

  • 1. Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD.
    Krishnasamy R, Tan SJ, Hawley CM, Johnson DW, Stanton T, Lee K, Mudge DW, Campbell S, Elder GJ, Toussaint ND, Isbel NM.
    BMC Nephrol; 2017 Sep 04; 18(1):281. PubMed ID: 28870151
    [Abstract] [Full Text] [Related]

  • 2. FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages.
    Desjardins L, Liabeuf S, Renard C, Lenglet A, Lemke HD, Choukroun G, Drueke TB, Massy ZA, European Uremic Toxin (EUTox) Work Group.
    Osteoporos Int; 2012 Jul 04; 23(7):2017-25. PubMed ID: 22109743
    [Abstract] [Full Text] [Related]

  • 3. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, Spichtig D, Poster D, Wüthrich RP, Russmann S, Serra AL.
    Nephrol Dial Transplant; 2013 Feb 04; 28(2):352-9. PubMed ID: 23129826
    [Abstract] [Full Text] [Related]

  • 4. Association of serum adiponectin concentration with aortic arterial stiffness in chronic kidney disease: from the KNOW-CKD study.
    Kim CS, Bae EH, Ma SK, Park SK, Lee JY, Chung W, Lee K, Kim YH, Oh KH, Ahn C, Kim SW, Representing KNOW-CKD Study Group.
    Clin Exp Nephrol; 2017 Aug 04; 21(4):608-616. PubMed ID: 27514393
    [Abstract] [Full Text] [Related]

  • 5. Aortic Calcification and Arterial Stiffness Burden in a Chronic Kidney Disease Cohort with High Cardiovascular Risk: Baseline Characteristics of the Impact of Phosphate Reduction On Vascular End-Points in Chronic Kidney Disease Trial.
    Lioufas NM, Pedagogos E, Hawley CM, Pascoe EM, Elder GJ, Badve SV, Valks A, Toussaint ND, on behalf of the IMPROVE-CKD Investigators.
    Am J Nephrol; 2020 Aug 04; 51(3):201-215. PubMed ID: 32023606
    [Abstract] [Full Text] [Related]

  • 6. Changes in FGF-23, Neutrophil/Platelet Activation Markers, and Angiogenin in Advanced Chronic Kidney Disease and Their Effect on Arterial Stiffness.
    Choi HM, Kwon YE, Kim S, Oh DJ.
    Kidney Blood Press Res; 2019 Aug 04; 44(5):1166-1178. PubMed ID: 31553973
    [Abstract] [Full Text] [Related]

  • 7. Associations Between Kidney Disease Measures and Regional Pulse Wave Velocity in a Large Community-Based Cohort: The Atherosclerosis Risk in Communities (ARIC) Study.
    Kim ED, Tanaka H, Ballew SH, Sang Y, Heiss G, Coresh J, Matsushita K.
    Am J Kidney Dis; 2018 Nov 04; 72(5):682-690. PubMed ID: 30007506
    [Abstract] [Full Text] [Related]

  • 8. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
    Tranæus Lindblad Y, Olauson H, Vavilis G, Hammar U, Herthelius M, Axelsson J, Bárány P.
    Pediatr Nephrol; 2018 Jan 04; 33(1):147-157. PubMed ID: 28795324
    [Abstract] [Full Text] [Related]

  • 9. Soluble Klotho levels in diabetic nephropathy: relationship with arterial stiffness.
    Inci A, Sari F, Olmaz R, Coban M, Dolu S, Sarikaya M, Ellidag HY.
    Eur Rev Med Pharmacol Sci; 2016 Jul 04; 20(15):3230-7. PubMed ID: 27466997
    [Abstract] [Full Text] [Related]

  • 10. FGF23-klotho axis, bone fractures, and arterial stiffness in dialysis: a case-control study.
    Desbiens LC, Sidibé A, Ung RV, Fortier C, Munger M, Wang YP, Bisson SK, Marquis K, Agharazii M, Mac-Way F.
    Osteoporos Int; 2018 Oct 04; 29(10):2345-2353. PubMed ID: 29959497
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Arterial stiffness and 25-hydroxyvitamin D levels in chronic kidney disease patients.
    Akdam H, Alp A.
    Rev Assoc Med Bras (1992); 2017 Oct 04; 63(10):910-916. PubMed ID: 29267494
    [Abstract] [Full Text] [Related]

  • 15. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
    Wan M, Smith C, Shah V, Gullet A, Wells D, Rees L, Shroff R.
    Nephrol Dial Transplant; 2013 Jan 04; 28(1):153-61. PubMed ID: 23180879
    [Abstract] [Full Text] [Related]

  • 16. Klotho and Clinical Outcomes in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Edmonston D, Fuchs MAA, Burke EJ, Isakova T, Wolf M, Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.
    Am J Kidney Dis; 2024 Sep 04; 84(3):349-360.e1. PubMed ID: 38583756
    [Abstract] [Full Text] [Related]

  • 17. Randomized Controlled Trial for the Effect of Vitamin D Supplementation on Vascular Stiffness in CKD.
    Levin A, Tang M, Perry T, Zalunardo N, Beaulieu M, Dubland JA, Zerr K, Djurdjev O.
    Clin J Am Soc Nephrol; 2017 Sep 07; 12(9):1447-1460. PubMed ID: 28550081
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Increased Arterial Stiffness is an Independent Predictor of Renal Function Decline in Patients With Type 2 Diabetes Mellitus Younger Than 60 Years.
    Fountoulakis N, Thakrar C, Patel K, Viberti G, Gnudi L, Karalliedde J.
    J Am Heart Assoc; 2017 Mar 30; 6(4):. PubMed ID: 28360227
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 47.